Figure 1.
Kaplan-Meier plots of (A) local tumor progression–free survival, (B) recurrence-free survival, and (C) overall survival after ablation of CLM among patients with wild-type RAS (red lines) and mutant RAS (blue lines) status.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.